1. Association of Accessible Medications. 2017 generic drug access and savings in the United States report. https://www.accessiblemeds.org/resources/blog/2017-generic-drug-access-and-savings-us-report. Accessed August 14, 2017.
2. Generic Drug User Fee Act Reauthorization (GDUFA II), Biosimilar User Fee Act Reauthorization (BsUFA II). https://www.fda.gov/NewsEvents/Testimony/ucm548273.htm. Accessed August 14, 2017.
3. Uhl K, Peters JR, Chazin H. The FDA ensures quality and safety of generic drugs in the United States. ASCO Post, December 10, 2016. http://www.ascopost.com/issues/december-10-2016/the-fda-ensures-quality-and-safety-of-generic-drugs-in-the-united-states/. Accessed August 17, 2017.
4. FDA. Generic drugs undergo rigorous FDA scrutiny. https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm340343.htm. Accessed June 26, 2017.
5. Orange Book preface. https://www.fda.gov/Drugs/DevelopmentApprovalProcess/ucm079068.htm. Accessed August 14, 2017.